MiMedx Group Inc (MDXG)
6.29
+0.13
(+2.11%)
USD |
NASDAQ |
Apr 19, 16:00
6.29
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Cash from Financing (TTM): -8.57M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -8.57M |
September 30, 2023 | 0.436M |
June 30, 2023 | 0.196M |
March 31, 2023 | 0.452M |
December 31, 2022 | -0.58M |
September 30, 2022 | -0.624M |
June 30, 2022 | -0.904M |
March 31, 2022 | -2.08M |
December 31, 2021 | -3.352M |
September 30, 2021 | -4.617M |
June 30, 2021 | 62.27M |
March 31, 2021 | 61.43M |
December 31, 2020 | 61.56M |
September 30, 2020 | 61.67M |
June 30, 2020 | -6.775M |
March 31, 2020 | 61.73M |
December 31, 2019 | 62.86M |
September 30, 2019 | 63.71M |
June 30, 2019 | 65.20M |
March 31, 2019 | -1.887M |
December 31, 2018 | -8.934M |
September 30, 2018 | -33.24M |
June 30, 2018 | -60.58M |
March 31, 2018 | -55.34M |
December 31, 2017 | -60.39M |
Date | Value |
---|---|
September 30, 2017 | -35.10M |
June 30, 2017 | -14.11M |
March 31, 2017 | -18.18M |
December 31, 2016 | -8.151M |
September 30, 2016 | -27.38M |
June 30, 2016 | -24.54M |
March 31, 2016 | -28.28M |
December 31, 2015 | -36.22M |
September 30, 2015 | -16.80M |
June 30, 2015 | -13.14M |
March 31, 2015 | -14.38M |
December 31, 2014 | -2.146M |
September 30, 2014 | 34.63M |
June 30, 2014 | 35.98M |
March 31, 2014 | 40.68M |
December 31, 2013 | 40.63M |
September 30, 2013 | 3.205M |
June 30, 2013 | 7.919M |
March 31, 2013 | 7.509M |
December 31, 2012 | 6.61M |
September 30, 2012 | 11.32M |
June 30, 2012 | 5.716M |
March 31, 2012 | 8.485M |
December 31, 2011 | 10.14M |
September 30, 2011 | 8.091M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-8.57M
Minimum
Dec 2023
65.20M
Maximum
Jun 2019
24.95M
Average
0.436M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
TELA Bio Inc | 46.27M |
Amylyx Pharmaceuticals Inc | 3.543M |
CEL-SCI Corp | 8.678M |
AIM ImmunoTech Inc | 0.485M |
IGC Pharma Inc | 2.856M |